Page 9 - David Ricks News Today

Around 4:20 p.m. March 27, residents of a south Scottsdale trailer park answered a bang on their door.

The drugs giant is asking its shareholders to approve a performance-based pay policy that could hand Pascal Soriot rewards of up to £18.7 million this year.

Eli Lilly’s popular weight loss drugs have "limited availability" through the end of April

The newest weight loss drug on the market is facing a shortage of supply, according to the U.S. Food and Drug Administration. The FDA approved Zepbound in November as a weight loss management treatment for people with obesity, or those who are overweight with at least one related underlying condition, such as high blood pressure. As a diabetes drug, Zepbound is sold under the brand name Mounjaro, as the two medications contain the same active ingredient, tirzepatide.

Zepbound was approved by the FDA for weight loss in November.

The FDA says some doses of the drug will be in limited supply until the end of April

Potential ballot issues to be decided by Scottsdale Council

Eli Lilly has commenced phase three clinical trials in India for a new oral weight-loss drug called orforglipron. The trials aim to assess its safety and efficacy compared to insulin glargine in individuals with type-two diabetes and obesity or overweight at an increased cardiovascular risk. The companys spokesperson in India mentioned ongoing clinical studies on novel products, including orforglipron.

A 76-year-old man has been arrested on suspicion of stabbing his roommate to death in Scottsdale.

A man accused of stabbing his longtime roommate during an argument at a Scottsdale mobile home has been arrested.